Strategic M&A Surges to Six-Year High Despite Public Market Headwinds
Our comprehensive analysis reveals over $30 billion in strategic acquisitions and robust venture funding activity across healthcare and life sciences in the first half of 2025. Key highlights include $10.2 billion in venture fund closes, breakthrough AI-driven platforms commanding premium valuations, and continued investor appetite for therapeutics, med-tech, and digital health innovations.